Trademark: 97886578
Word
AGENUS
Status
Pending
Status Code
641
Status Date
Thursday, August 17, 2023
Serial Number
97886578
Mark Type
4000
Filing Date
Thursday, April 13, 2023

Trademark Owner History

Classifications
5 Pharmaceuticals; therapeutics; biologics; monoclonal antibodies; antibodies; adjuvants; vaccines; cell therapy; cells for medical or clinical use; pharmaceutical preparations and products for the treatment of disease; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical research and development; drug discovery platform; scientific research and development; medical research and development; software for use in pharmaceutical research and development; pharmaceutical research and development in the fields of cancer, immunology, and immuno-oncology; drug development platform; platform as a services (PaaS) featuring computer software for drug development; software for predicting clinical benefit and patient response; custom manufacturing of pharmaceuticals and therapeutics; contract manufacturing of pharmaceuticals and therapeutics

Trademark Events
Feb 20, 2024
Teas Response To Office Action Received
Nov 15, 2023
Application Extension Granted/Receipt Provided
Nov 15, 2023
Application Extension To Response Period - Received
Aug 17, 2023
Notification Of Non-Final Action E-Mailed
Aug 17, 2023
Non-Final Action E-Mailed
Aug 17, 2023
Non-Final Action Written
Aug 13, 2023
Assigned To Examiner
May 8, 2023
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24